Search research articles
Contact Us
Filters
Showing results (341-350 of 376) with videos related to
Page
of 38
Sort By:
BMJ Oncology
|
June 16, 2025
Smoking habit and long-term colorectal cancer incidence by exome-wide mutational and neoantigen loads: evidence based on the prospective cohort incident-tumour biobank method
Tsuyoshi Hamada, Tomotaka Ugai, Carino Gurjao, et al.
Nature Cancer
|
January 9, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Tejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Nature
|
February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromise
Ergün Sahin, Simona Colla, Marc Liesa, et al.
Cell Reports
|
May 7, 2016
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, et al.
Cell Reports
|
October 21, 2016
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, et al.
Cell
|
April 17, 2018
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Sachet A Shukla, Pavan Bachireddy, Bastian Schilling, et al.
Cancer Cell
|
September 22, 2023
ZNF683 marks a CD8<sup>+</sup> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
Erin M Parry, Camilla K Lemvigh, Stephanie Deng, et al.
Oncoimmunology
|
June 15, 2018
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
Tsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, et al.
Nature Genetics
|
May 10, 2016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D Campbell, Anton Alexandrov, Jaegil Kim, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 376) with videos related to
Sort By:
Page
of 38
BMJ Oncology
|
June 16, 2025
Smoking habit and long-term colorectal cancer incidence by exome-wide mutational and neoantigen loads: evidence based on the prospective cohort incident-tumour biobank method
Tsuyoshi Hamada, Tomotaka Ugai, Carino Gurjao, et al.
Nature Cancer
|
January 9, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Tejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Nature
|
February 11, 2011
Telomere dysfunction induces metabolic and mitochondrial compromise
Ergün Sahin, Simona Colla, Marc Liesa, et al.
Cell Reports
|
May 7, 2016
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, et al.
Cell Reports
|
October 21, 2016
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
Marios Giannakis, Xinmeng Jasmine Mu, Sachet A Shukla, et al.
Cell
|
April 17, 2018
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
Sachet A Shukla, Pavan Bachireddy, Bastian Schilling, et al.
Cancer Cell
|
September 22, 2023
ZNF683 marks a CD8<sup>+</sup> T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome
Erin M Parry, Camilla K Lemvigh, Stephanie Deng, et al.
Oncoimmunology
|
June 15, 2018
TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor <i>CD274</i> (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas
Tsuyoshi Hamada, Thing Rinda Soong, Yohei Masugi, et al.
Nature Genetics
|
May 10, 2016
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
Joshua D Campbell, Anton Alexandrov, Jaegil Kim, et al.
Blood Cancer Discovery
|
November 5, 2025
PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor-Resistant Chronic Lymphocytic Leukemia
Britten K Gordon, Elizabeth M Muhowski, Jyotsana Singh, et al.
Page
of 38